Key Agenda Items
The Board of Directors meeting is scheduled for Thursday, October 22, 2026. The primary agenda items to be considered and approved are:
- The unaudited Standalone Financial Results of the Company for the second quarter and half year ended September 30, 2026.
- The unaudited Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2026.
- The Limited Review Report of the Statutory Auditors on the aforementioned financial results.
- Any other matter.
Trading Window Closure
Pursuant to the Company's Code of Practices & Procedures and SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the Company's securities was closed for all Designated Persons, Connected Persons, and their immediate relatives. The closure became effective from October 1, 2026, as per a prior communication dated September 25, 2026.
The trading window will remain closed and is scheduled to reopen after 48 hours from the time the unaudited Standalone and Consolidated Financial Results for Q2 and H1 FY27 are generally made available to the public.